3-Acetyl-11-Keto-Beta-Boswellic Acid Inhibits Adipogenesis by Suppressing Autophagy and Inducing AMPK Phosphorylation in 3T3-L1 Cells
Cellular Physiology and Biochemistry · 2025
DOI: 10.33594/000000830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Physiology and Biochemistry, 2025. Verfasst von Faizullah Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Natural and Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman. Hauptthemen laut MEDLINE: Autophagy, Adipogenesis, Triterpenes, AMP-Activated Protein Kinases.
Abstract (Originalsprache)
Background/Aims: Adipogenesis, a process involving preadipocyte differentiation and lipid droplet accumulation, is linked to obesity. 3-Acetyl-11-keto-beta-boswellic acid (AKBA), a frankincense-derived triterpene, has anti-inflammatory and cancer properties, but its role in regulating adipocyte differentiation and adipogenesis remains unclear.
Methods
3T3-L1 preadipocytes were induced to differentiate into adipocytes using a differentiation cocktail, with or without varying concentrations of AKBA. Cell viability was assessed using the MTT assay, while lipid accumulation was quantified through Oil Red O staining in the differentiated 3T3-L1 adipocytes. Apoptosis was determined using the FITC (fluorescein isothiocyanate) annexin V apoptosis detection kit. Expression of pro- and anti-apoptotic proteins Bax and Bcl2, adipogenic transcription factors, lipid accumulation-related proteins, and autophagy marker proteins were analyzed via Western blotting. Additionally, molecular docking simulations were conducted to investigate the binding affinity and interactions between the bioactive compounds and the targeted proteins.
Results
AKBA treatment inhibited adipocyte differentiation by suppressing the protein levels of essential adipogenic markers CCAAT/enhancer binding protein beta (C/EBPβ), CCAAT/enhancer binding protein alpha (C/EBPα), and peroxisome proliferator-activated receptor gamma (PPARγ). Further, AKBA treatment significantly reduced lipid accumulation and increased apoptosis in 3T3-L1 cells by increasing Bax/Bcl2 ratio. Notably, AKBA treatment profoundly reduced autophagy indicators, including ATG5 and LC3b protein expression in differentiated 3T3-L1 cells, concurrent with increased AMPK phosphorylation (P-AMPK). Further, a molecular docking study revealed that AKBA can block PPARγ and ATG5.
Conclusion
The results indicate that AKBA exhibits anti-adipogenesis effects by suppressing adipocyte-specific transcription factors C/EBPα and PPARγ, autophagy-related marker ATG5, promoting apoptosis and activating AMPK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural and Medical Sciences Research Center, University of Nizwa, Nizwa 616, Oman.
- Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan 23200, Khyber Pakhtunkhwa, Pakistan.
- Department of Pharmacy, Korea University, Sejong 20019, South Korea.
- Department of Pharmaceutical Sciences, College of Pharmacy, Texas A & M University, College Station, Texas 77843, USA.
Zitieren
APA
Khan, F., Waqas, M., Moghtaderi, H., Rehman, N. U., Avula, S. K., Khan, H., Choudhury, M., Al-Harrasi, A., & Rahman, S. M. (2025). 3-Acetyl-11-Keto-Beta-Boswellic Acid Inhibits Adipogenesis by Suppressing Autophagy and Inducing AMPK Phosphorylation in 3T3-L1 Cells. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000830
Vancouver
Khan F, Waqas M, Moghtaderi H, Rehman NU, Avula SK, Khan H, et al. 3-Acetyl-11-Keto-Beta-Boswellic Acid Inhibits Adipogenesis by Suppressing Autophagy and Inducing AMPK Phosphorylation in 3T3-L1 Cells. Cellular Physiology and Biochemistry. 2025. doi:10.33594/000000830
BibTeX
@article{Khan2025,
author = {Khan, Faizullah and Waqas, Muhammad and Moghtaderi, Hassan and Rehman, Najeeb Ur and Avula, Satya Kumar and Khan, Haroon and Choudhury, Mahua and Al-Harrasi, Ahmed and Rahman, Shaikh Mizanoor},
title = {3-Acetyl-11-Keto-Beta-Boswellic Acid Inhibits Adipogenesis by Suppressing Autophagy and Inducing AMPK Phosphorylation in 3T3-L1 Cells},
journal = {Cellular Physiology and Biochemistry},
year = {2025},
doi = {10.33594/000000830}
}
EUVIMED